The novel approach of tirzepatide peptide represents a exciting development in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide608339.snack-blog.com/42242823/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment